Functional roles for C5a and C5aR but not C5L2 in the pathogenesis of human and experimental cerebral malaria

Infection and Immunity

Volumn 82, Issue 1, 2014, Pages 371-379

  Kim, Hani ^a,b   Erdman, Laura K ^a,b   Lu, Ziyue ^a,b   Serghides, Lena ^a,b   Zhong, Kathleen ^a,b   Dhabangi, Aggrey ^c   Musoke, Charles ^c   Gerard, Craig ^d   Cserti Gazdewich, Christine ^a   Conrad Liles, W ^a,b,e   Kain, Kevin C ^a,b  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES   (Uganda)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR; COMPLEMENT COMPONENT C5AL2; EVANS BLUE; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN MALARIA; CASE CONTROL STUDY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTHELIAL DYSFUNCTION; EXPERIMENTAL INFECTION; EXTRAVASATION; FEMALE; HUMAN; IMMUNOPATHOGENESIS; INFANT; INFLAMMATION; MALARIA; MALE; MOUSE; NONHUMAN; PLASMODIUM BERGHEI; PRIORITY JOURNAL; SURVIVAL; UGANDA;

EID: 84890822146     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01246-13     Document Type: Article

References (66)

1. Murray CJL, Rosenfeld LC, Lim SS, Andrews KG, Foreman KJ, Haring D, Fullman N, Naghavi M, Lozano R, Lopez AD. 2012. Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet 379:413-431. http://dx.doi.org/10.1016/S0140-6736(12)60034-8.
2. WHO. 2011. World malaria report. World Health Organization, Geneva, Switzerland.
3. Dondorp A, Nosten F, Stepniewska K, Day N, White N. 2005. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet 366:717-725. http://dx.doi.org/10.1016/S0140-6736(05)67176-0.
4. Dondorp AM, Fanello CI, Hendriksen ICE, Gomes E, Seni A, Chhaganlal KD, Bojang K, Olaosebikan R, Anunobi N, Maitland K, Kivaya E, Agbenyega T, Nguah SB, Evans J, Gesase S, Kahabuka C, Mtove G, Nadjm B, Deen J, Mwanga-Amumpaire J, Nansumba M, Karema C, Umulisa N, Uwimana A, Mokuolu OA, Adedoyin OT, Johnson WBR, Tshefu AK, Onyamboko MA, Sakulthaew T, Ngum WP, Silamut K, Stepniewska K, Woodrow CJ, Bethell D, Wills B, Oneko M, Peto TE, von Seidlein L, Day NPJ, White NJ. 2010. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet 376:1647-1657. http://dx.doi.org/10.1016/S0140-6736(10)61924-1.
5. Conroy A, Glover SJ, Hawkes M, Erdman LK, Seydel KB, Taylor TE, Molyneux ME, Kain KC. 2012. Angiopoietin-2-levels are associated with retinopathy and predict mortality in Malawian children with cerebral malaria: a retrospective case-control study. Crit. Care Med. 40:952-959. http://dx.doi.org/10.1097/CCM.0b013e3182373157.
6. Beare NAV, Harding SP, Taylor TE, Lewallen S, Molyneux ME. 2009. Perfusion abnormalities in children with cerebral malaria and malarial retinopathy. J. Infect. Dis. 199:263-271. http://dx.doi.org/10.1086/595735.
7. Hunt NH, Grau GE. 2003. Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. Trends Immunol. 24:491-499. http://dx.doi.org/10.1016/S1471-4906(03)00229-1.
8. John CC, Panoskaltsis-Mortari A, Opoka RO, Park GS, Orchard PJ, Jurek AM, Idro R, Byarugaba J, Boivin MJ. 2008. Cerebrospinal fluid cytokine levels and cognitive impairment in cerebral malaria. Am. J. Trop. Med. Hyg. 78:198-205.
9. Ringwald P, Peyron F, Vuillez JP, Touze JE, Le Bras J, Deloron P. 1991. Levels of cytokines in plasma during Plasmodium falciparum malaria attacks. J. Clin. Microbiol. 29:2076-2078.
10. Turner GD, Morrison H, Jones M, Davis TME, Looareesuwan S, Buley ID, Gatter KC, Newbold CI, Pukritayakamee S, Nagachinta B, White NJ, Berendt AR. 1994. An immunohistochemical study of the pathology of fatal malaria: evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule-1 in cerebral sequestration. Am. J. Pathol. 145:1057-1069.
11. Grau GE, Pointaire P, Piguet PF, Vesin C, Rosen H, Stamenkovic I, Takei F, Vassalli P. 1991. Late administration of monoclonal antibody to leukocyte function-antigen 1 abrogates incipient murine cerebral malaria. Eur. J. Immunol. 21:2265-2267. http://dx.doi.org/10.1002/eji.1830210939.
12. Favre N, Da Laperousaz C, Ryffel B, Weiss NA, Imhof BA, Rudin W, Lucas R, Piguet PF. 1999. Role of ICAM-1 (CD54) in the development of murine cerebral malaria. Microbes Infect. 1:961-968. http://dx.doi.org/10.1016/S1286-4579(99)80513-9.
13. Fauconnier M, Palomo J, Bourigault M-L, Meme S, Szeremeta F, Beloeil J-C, Danneels A, Charron S, Rihet P, Ryffel B, Quesniaux V. 2012. IL-12R-beta2 is essential for the development of experimental cerebral malaria. J. Immunol. 188:1905-1914. http://dx.doi.org/10.4049/jimmunol.1101978.
14. Zipfel PF, Skerka C. 2009. Complement regulators and inhibitory proteins. Nat. Rev. Immunol. 9:729-740.
15. Huber-Lang M, Sarma JV, Zetoune FS, Rittirsch D, Neff TA, McGuire SR, Lambris JD, Warner RL, Flierl MA, Hoesel LM, Gebhard F, Younger JG, Drouin SM, Wetsel RA, Ward PA. 2006. Generation of C5a in the absence of C3: a new complement activation pathway. Nat. Med. 12:682-687. http://dx.doi.org/10.1038/nm1419.
16. Huber-Lang M, Younkin EM, Sarma JV, Riedemann N, McGuire SR, Lu KT, Kunkel R, Younger JG, Zetoune FS, Ward PA. 2002. Generation of C5a by phagocytic cells. Am. J. Pathol. 161:1849-1859. http://dx.doi.org/10.1016/S0002-9440(10)64461-6.
17. Conroy A, Serghides L, Finney C, Owino SO, Kumar S, Gowda DC, Liles WC, Moore JM, Kain KC. 2009. C5a enhances dysregulated inflammatory and angiogenic responses to malaria in vitro: potential implications for placental malaria. PLoS One 4:e4953. http://dx.doi.org/10.1371/journal.pone.0004953.
18. Bosmann M, Ward PA. 2012. Role of C3, C5 and anaphylatoxin receptors in acute lung injury and in sepsis. Adv. Exp. Med. Biol. 946:147-159. http://dx.doi.org/10.1007/978-1-4614-0106-3_9.
19. Rittirsch D, Flierl MA, Nadeau BA, Day DE, Huber M, Mackay CR, Zetoune FS, Gerard NP, Cianflone K, Gerard C, Sarma JV, Ward PA. 2010. Functional roles for C5a receptors in sepsis. Nat. Med. 14:551-557.
20. Langer H, Chung K, Oriova V, Choi E, Kaul S, Kruhlak M, Alatsatianos M, DeAngelis R, Roche P, Magotti P, Li X, Economopoulou M, Rafail S, Lambris J, Chavakis T. 2010. Complement-mediated inhibition of neovascularization reveals a point of convergence between innate immunity and angiogenesis. Blood 116:4395-4403. http://dx.doi.org/10.1182/blood-2010-01-261503.
21. Fonseca MI, McGuire SO, Counts SE, Tenner AJ. 2013. Complement activation fragment C5a receptors, CD88 and C5L2, are associated with neurofibrillary pathology. J. Neuroinflammation http://dx.doi.org/10.1186/1742-2094-10-25.
22. Leslie M. 2012. The new view of complement. Science 337:1034-1037. http://dx.doi.org/10.1126/science.337.6098.1034.
23. Silver KL, Higgins SJ, McDonald CR, Kain KC. 2010. Complement driven innate immune response to malaria: fuelling severe malarial diseases. Cell. Microbiol. 12:1036-1045. http://dx.doi.org/10.1111/j.1462-5822.2010.01492.x.
24. Ramos TN, Darley MM, Hu X, Billker O, Rayner JC, Ahras M, Wohler JE, Barnum SR. 2011. Cutting edge: the membrane attack complex of complement is required for the development of murine experimental cerebral malaria. J. Immunol. 186:6657-6660. http://dx.doi.org/10.4049/jimmunol.1100603.
25. Patel SN, Berghout J, Lovegrove FE, Ayi K, Conroy A, Serghides L, Min-oo G, Gowda GDC, Sarma JV, Rittirsch D, Ward PA, Liles WC, Gros P, Kain KC. 2008. C5 deficiency and C5a or C5aR blockade protects against cerebral malaria. J. Exp. Med. 205:1133-1143. http://dx.doi.org/10.1084/jem.20072248.
26. Okinaga S, Slattery D, Humbles A, Zsengeller Z, Morteau O, Kinrade MB, Brodbeck RM, Krause JE, Choe H-R, Gerard NP, Gerard C. 2003. C5L2, a nonsignaling C5a binding protein. Biochemistry 42:9406-9415. http://dx.doi.org/10.1021/bi034489v.
27. Gerard N, Bao L, Xiao-Ping H, Eddy RJ, Shows T, Gerard C. 1993. Human chemotaxis receptor genes cluster at 19q13.3-13.4. Characterization of the human C5a receptor gene. Biochemistry 32:1243-1250.
28. Cain SA, Monk PN. 2002. The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg(74). J. Biol. Chem. 277:7165-7169. http://dx.doi.org/10.1074/jbc.C100714200.
29. Gerard NP, Lu B, Liu P, Craig S, Fujiwara Y, Okinaga S, Gerard C. 2005. An anti-inflammatory function for the complement anaphylatoxin C5a-binding protein, C5L2. J. Biol. Chem. 280:39677-39680. http://dx.doi.org/10.1074/jbc.C500287200.
30. Zhang X, Schmudde I, Laumonnier Y, Pandey MK, Clark JR, Konig P, Gerard NP, Gerard C, Wills-Karp M, Köhl J. 2011. A critical role for C5L2 in the pathogenesis of experimental allergic asthma. J. Immunol. 185:6741-6752. http://dx.doi.org/10.4049/jimmunol.1000892.
31. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. 2002. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3:research0034.0031-research0034.0011. http://dx.doi.org/10.1186/gb-2002-3-7-research0034.
32. Urbonaviciute V, Furnrohr BG, Weber C, Haslbeck M, Wilhelm S, Herrmann M, Voll RE. 2007. Factors masking HMGB1in human serum and plasma. J. Leukoc. Biol. 81:67-74. http://dx.doi.org/10.1189/jlb.0306196.
33. Cserti-Gazdewich CM, Dhabangi A, Musoke C, Ssewanyana I, Ddungu H, Nakiboneka-Ssenabulya D, Nabukeera-Barungi N, Mpimbaza A, Dzik WH. 2012. Cytoadherence in paediatric malaria: ABO blood group, CD36, and ICAM1 expression and severe Plasmodium falciparum infection. Br. J. Haematol. 159:223-236. http://dx.doi.org/10.1111/bjh.12014.
34. Erdman LK, Dhabangi A, Musoke C, Conroy AL, Hawkes M, Higgins S, Rajwans N, Wolofsky KT, Streiner DL, Liles WC, Cserti-Gazdewich CM, Kain KC. 2011. Combinations of host biomarkers predict mortality among Ugandan children with severe malaria: a retrospective case-control study. PLoS One 6:e17440. http://dx.doi.org/10.1371/journal.pone.0017440.
35. WHO. 2000. Severe falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 94(Suppl):S1-S90.
36. Rest JR. 1982. Cerebral malaria in inbred mice. I. A new model and its pathology. Trans. R. Soc. Trop. Med. Hyg. 76:410-415. http://dx.doi.org/10.1016/0035-9203(82)90203-6.
37. Clark I, Gray K, Rockett E, Cowden W, Rockett K, Ferrante A, Aggarwal B. 1992. Increased lymphotoxin in human malarial serum, and the ability of this cytokine to increase plasma interleukin-6 and cause hypoglycaemia in mice: implications for malarial pathology. Trans. R. Soc. Trop. Med. Hyg. 86:602-607. http://dx.doi.org/10.1016/0035-9203(92)90144-2.
38. Hanum P, Hayano M, Kojima S. 2003. Cytokine and chemokine responses in a cerebral malaria-susceptible or-resistant strain of mice to Plasmodium bergheiANKAinfection: early chemokine expression in the brain. Int.Immunol. 15:633-640. http://dx.doi.org/10.1093/intimm/dxg065.
39. Grau GE, Fajardo LF, Piguet PF, Allet B, Lambert PH, Vassalli P. 1987. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science 237:1210-1212. http://dx.doi.org/10.1126/science.3306918.
40. Yanai H, Ban T, Taniguchi T. 2012. High-mobility group box family of proteins: ligand and sensor for innate immunity. Trends Immunol. 33:633-640. http://dx.doi.org/10.1016/j.it.2012.10.005.
41. Higgins S, Xing K, Kim H, Kain D, Wang F, Dhabangi A, Musoke D, Cserti-Gazdewich C, Tracey KJ, Kain K, Liles W. 2013. Systemic release of high mobility group box 1 (HMGB1) protein is associated with severe and fatal Plasmodium falciparum malaria. Malar. J. 12:105. http://dx.doi.org/10.1186/1475-2875-1112-1105.
42. Riley EM, Couper KN, Helmby H, Hafalla JC, de Souza JB, Langhorne J, Jarra WB, Zavala F. 2010. Neuropathogenesis of human and murine malaria. Trends Parasitol. 26:277-278. http://dx.doi.org/10.1016/j.pt.2010.03.002.
43. Brown H, Hien TT, Day N, Mai NT, Chuong LV, Chau TT, Loc PP, Phu NH, Bethell D, Farrar J, Gatter K, White N, Turner G. 1999. Evidence of blood-brain barrier dysfunction in human cerebral malaria. Neuropathol. Appl. Neurobiol 25:331-340. http://dx.doi.org/10.1046/j.1365-2990.1999.00188.x.
44. Fiedler U, Augustin HG. 2006. Angiopoietins: a link between angiogenesis and inflammation. Trends Immunol. 27:552-558. http://dx.doi.org/10.1016/j.it.2006.10.004.
45. Lovegrove FE, Tangpukdee N, Opoka RO, Lafferty EI, Rajwans N, Hawkes M, Krudsood S, Looareesuwan S, John CC, Liles WC, Kain KC. 2009. Serum angiopoietin-1 and-2 levels discriminate cerebral malaria from uncomplicated malaria and predict clinical outcome in African children. PLoS One 4:e4912. http://dx.doi.org/10.1371/journal.pone.0004912.
46. Yeo TW, Lampah DA, Gitawati R, Tjitra E, Kenangalem E, Piera K, Price RN, Duffull SB, Celermajer DS, Anstey NM. 2008. Angiopoietin-2 is associated with decreased endothelial nitric oxide and poor clinical outcome in severe falciparum malaria. Proc. Natl. Acad. Sci. U.S.A. 105:17097-17102. http://dx.doi.org/10.1073/pnas.0805782105.
47. Serghides L, Kim H, Lu Z, Kain DC, Miller C, Francis RC, Liles WC, Zapol WM, Kain KC. 2011. Inhaled nitric oxide reduces endothelial activation and parasite accumulation in the brain, and enhances survival in experimental cerebral malaria. PLoS One 6:e27714. http://dx.doi.org/10.1371/journal.pone.0027714.
48. Finney C, Hawkes C, Kain D, Dhabangi A, Musoke C, Cserti-Gazdewich C, Oravecz T, Liles W, Kain K. 2011. S1P is associated with protection in human and experimental cerebral malaria. Mol. Med. 17:717-725. http://dx.doi.org/10.2119/molmed.2010.00214.
49. Taylor TE, Fu WJ, Carr RA, Whitten RO, Mueller JS, Fosiko NG, Lewallen S, Liomba NG, Molyneux ME. 2004. Differentiating the pathologies of cerebral malaria by postmortem parasite counts. Nat. Med. 10:143-145. http://dx.doi.org/10.1038/nm986.
50. Hashimoto M, Hirota K, Yoshitomi H, Maeda S, Teradaira S, Akizuki S, Prieto-Martin P, Nomura T, Sakaguchi N, Köhl J, Heyman B, Takahashi M, Fujita T, Mimori T, Sakaguchi S. 2010. Complement drives Th17 cell differentiation and triggers autoimmune arthritis. J. Exp. Med. 207:1135-1143. http://dx.doi.org/10.1084/jem.20092301.
51. Yeo TW, Lampah DA, Gitawati R, Tjitra E, Kenangalem E, McNeil YR, Darcy CJ, Granger DL, Weinberg JB, Lopansri BK, Price RN, Duffull SB, Celermajer DS, Anstey NM. 2008. Recovery of endothelial function in severe falciparum malaria: relationship with improvement in plasma L-arginine and blood lactate concentrations. J. Infect. Dis. 198:602-608. http://dx.doi.org/10.1086/590209.
52. Grau GE, Taylor TE, Molyneux ME, Wirima JJ, Vassalli P, Hommel M, Lambert P-H. 1989. Tumor necrosis factor and disease severity in children with falciparum malaria. N. Engl. J. Med. 320:1586-1591. http://dx.doi.org/10.1056/NEJM198906153202404.
53. Cserti-Gazdewich CM, Dzik WH, Erdman L, Ssewanyana I, Dhabangi A, Musoke C, Kain KC. 2010. Combined measurement of soluble and cellular ICAM-1 among children with Plasmodium falciparum malaria in Uganda. Malar. J. 9:233. http://dx.doi.org/10.1186/1475-2875-9-233.
54. Nacer A, Movila A, Baer K, Mikolajczak SA, Kappe SH, Frevert U. 2012. Neuroimmunological blood brain barrier opening in experimental cerebral malaria. PLoS Pathog. 8:e1002982. http://dx.doi.org/10.1371/journal.ppat.1002982.
55. Thumwood C, Hunt NH, Clark IA, Cowden WB. 1988. Breakdown of the blood-brain barrier in murine cerebral malaria. Parasitology 96:579-589. http://dx.doi.org/10.1017/S0031182000080203.
56. Jacob A, Hack B, Chiang E, Garcia JGN, Quigg RJ, Alexander JJ. 2010. C5a alters blood-brain barrier integrity in experimental lupus. FASEB J. 24:1682-1688. http://dx.doi.org/10.1096/fj.09-138834.
57. Jacob A, Hack B, Chen P, Quigg RJ, Alexander JJ. 2011. C5a/CD88 signaling alters blood-brain barrier integrity in lupus through nuclear factor-kappaB. J. Neurochem. 119:1041-1051. http://dx.doi.org/10.1111/j.1471-4159.2011.07490.x.
58. Chen NJ, Mirtsos C, Suh D, Lu YC, Lin WJ, McKerlie C, Lee T, Baribault H, Tian H, Yeh WC. 2007. C5L2 is critical for the biological activities of the anaphylatoxins C5a and C3a. Nature 446:203-207. http://dx.doi.org/10.1038/nature05559.
59. Baelder R, Fuchs B, Bautsch W, Zwirner J, Kohl J, Hoymann HG, Glaab T, Erpenbeck V, Krug N, Braun A. 2005. Pharmacological targeting of anaphylatoxin receptors during the effector phase of allergic asthma suppresses airway hyperresponsiveness and airway inflammation. J. Immunol. 174:783-789. http://www.jimmunol.org/content/174/2/783.long.
60. Conroy AL, Silver KL, Zhong K, Rennie M, Ward PA, Sarma JV, Molyneux ME, Sled J, Fletcher JF, Rogerson S, Kain KC. 2013. Complement activation and the resulting placental vascular insufficiency drives fetal growth restriction associated with placental malaria. Cell Host Microbe 13:215-226. http://dx.doi.org/10.1016/j.chom.2013.01.010.
61. Ramos TN, Darley MM, Weckbach S, Stahel PF, Tomlinson S, Barnum SR. 2012. The C5 convertase is not required for activation of the terminal complement pathway in murine experimental cerebral malaria. J. Biol. Chem. 287:24734-24738. http://dx.doi.org/10.1074/jbc.C112.378364.
62. Rojanasthien S, Surakamolleart V, Boonpucknavig S, Isarangkura P. 1992. Hematological and coagulation studies in malaria. J. Med. Assoc. Thai. 75(Suppl 1):190-194.
63. Srichaikul T, Pulket C, Sirisatepisarn T, Prayoonwiwat W. 1988. Platelet dysfunction in malaria. Southeast Asian J. Trop. Med. Public Health 19:225-233.
64. Clemens R, Pramoolsinsap C, Lorenz R, Pukrittayakamee S, Bock HL, White NJ. 1994. Activation of the coagulation cascade in severe falciparum malaria through the intrinsic pathway. Br. J. Haematol. 87:100-105. http://dx.doi.org/10.1111/j.1365-2141.1994.tb04877.x.
65. Wetsel RA, Kolb WP. 1983. Expression of C5a-like biological activities by the fifth component of human complement (C5) upon limited digestion with noncomplement enzymes without release of polypeptide fragments. J. Exp. Med. 157:2029-2048. http://dx.doi.org/10.1084/jem.157.6.2029.
66. Dasari P, Heber SD, Beisele M, Torzewski M, Reifenberg K, Orning C, Fries A, Zapf AL, Baumeister S, Lingelbach K, Udomsangpetch R, Bhakdi SC, Reiss K, Bhakdi S. 2012. Digestive vacuole of Plasmodium falciparum released during erythrocyte rupture dually activates complement and coagulation. Blood 119:4301-4310. http://dx.doi.org/10.1182/blood-2011-11-392134.